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ABSTRACT 
 
Antibiotic is used abundantly over time. This study aimed to determine the profile of the use of antibiotics in units of DDD/100 bed-days, types of 
bacteria as well as the sensitivity of bacteria in the Surgery, Obstetrics and Gynecology, and Medical Ward of Bangil Regional General Hospital, 
Pasuruan in 2016. The study was conducted using a descriptive, cross-sectional study design and data collection was done retrospectively. The results 
showed that the most-used antibiotics in surgery and medical wards are the third-generation cephalosporins, whereas in Obstetrics and Gynecology is 
the first-generation cephalosporins. The total DDD per bed-days of the medical ward (53.76 DDD per bed-days) is higher than surgery ward (45.83 
DDD per bed-days) and Obstetrics and Gynecology ward (28.78 DDD per 100 bed-days). Only limited microbial culture perform during the study 
period. The most bacteria came from the isolates were Staphylococcus aureus and Escherichia coli. Antibiotic stewardship programme is urgently 
needed due to a high antibiotic use in the hospital. 
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INTRODUCTION 
 
The healthcare-associated infection (HAI) is one of the causes of 
high morbidity and mortality in the hospital. A prevalence survey 
in 10 geographically diverse states the USA, 183 hospitals, 
determine that the prevalence of HAI in acute care hospitals was 
4.0% (452 of 11,282 patients, had 1 or more healthcare-associated 
infection).1 The HAI prevalence in Southeast Asia was 5-10%.2 
A survey at two hospitals in Indonesia in 2001-2002 showed that 
the overall prevalence of HAI in hospital A was 5.9% and in 
hospital B 8.3%.3 The preventable aetiological factors for HAIs 
were controlled the infection transmission between patients by 
health workers and practice a rational antibiotic use.4 
 
Antibiotic indicated for bacterial infection. However, the growing 
population of bacteria being resistant to antibiotics threatens the 
success of antibiotics against infections. Inappropriate use of 
antibiotics will result in bacteria or microbes becoming resistant 
to the antibiotic, thus it causes the antibiotics losing their 
activity.5-7 A study about antibiotic use qualitatively with Gyssen 
method showed that in Dr. Soetomo General Hospital (Surabaya 
city) and Dr. Kariadi General Hospital Medical Center (Semarang 
city), among 84% patients in those hospitals who received an 
antibiotic, 32% of the antibiotics used were unclear indications.8 
 
Controlling the use of antibiotics is considered necessary in order 
to reduce the incidence of antibiotic resistance. One way of doing 
so is through the implementation of an Antibiotic Stewardship 
Program, which is an institutional or healthcare system approach 
to promote and monitor the use of antibiotics appropriately in 
order to maintain its effectiveness. The Ministry of Health in 
Indonesia has established an Antimicrobial Resistance Control 
Program (ARCP) team to support and oversee the running of 
Antibiotic Stewardship Program, which is recommended by the 
World Health Organization (WHO) and the Centers for Disease 
Control and Prevention (CDC). The Regulation of the Minister of 
Health No. 8 Year 2015 states that every hospital in Indonesia 
must implement an Antimicrobial Resistance Control Program 
optimally.9-11 
 
MATERIALS AND METHODS 
 
This research is conducted at Bangil Regional General Hospital. 
This hospital is a secondary care hospital with 272 bed. This 
retrospective, descriptive, observational cross-sectional study 
research material was data on antibiotic usage in the Surgery, 
Obstetrics and Gynecology, and Medical Ward of Bangil 
Regional General Hospital in 2016 obtained from the Pharmacy 
Installation and microbiology laboratory of Bangil Regional 
General Hospital; does not contain any studies with human 
participants. The study has an ethical clearance from the Health 
Research Ethics Committee of Politeknik Kesehatan Kemenkes 
Surabaya, Kementerian Kesehatan. Antibiotic usage was 
calculated and expressed in DDD units (defined daily dose) per 
100 bed-days, as well as calculated using Drug Utilization 90% 
(DU 90%) method to discover the most widely used antibiotics 
and percentage positive isolate. In addition, data on bacterial 
culture obtained from the microbiology laboratory of Bangil 
Regional General Hospital were also used in order to find out the 
types of bacteria and the percentage of bacterial sensitivity in the 
Surgery ward during the period of January – June 2016; 
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Obstetrics and Gynecology, and Medical ward during the period 
of July – December 2016.  
 
The equation to calculate DDD per 100 bed-days is modified from 
DDD/1000 population/day as follow:11-13 
 
   
…. Equation  1 
 
Several adjustments to the equation are i. the specific period of a 
month, ii. bed-days derived from the total length of stays of the 
patient. The DDD is the assumed average maintenance dose per 
day for a drug used for its main indication in adults. The 
calculation results of antibiotic use and percentage of bacterial 
sensitivity to antibiotics presented in tables. 
 
RESULTS 
 
There are 9679 patients in six-month periods; their average length 
of stay was 2.9 days, 2.5 days, 3.3 days in surgical, obstetrics and 
gynecology, medical ward respectively (Table 1). From a total of 
3016 patients in the surgical wards of Regional General Hospital 
Bangil, 572 patients received antibiotic therapy. In this research, 
more than 50% antibiotic use in the surgical and medical ward is 
third-generation cephalosporins and fluoroquinolones, whereas 
more than 70% antibiotic use in obstetrics and gynecology ward 
is first-generation cephalosporins and penicillins with extended 
spectrum (Table 2). The total number of DDD/100 bed-days was 
45.83, 28.78, 53.76 in surgical, obstetrics and gynecology, 
medical ward respectively, the detailed data could be seen in 
Table 3. According to these data, the most commonly used 
antibiotics in the surgical wards were ciprofloxacin (11.78 
DDD/100 bed-days); in obstetrics and gynecology was cefadroxil 
(11.64 DDD/100 bed-days); in the medical ward was ceftriaxone 
(12.99 DDD/100 bed-days). From the microbiology laboratory 
data, there are 124 isolates which were 48 Gram-negative bacteria 
and 76 Gram-positive bacteria, as shown in Table 4. These 
bacteria are Gram-negative bacteria, such as Escherichia coli 
(12), Acinetobacter sp. (8), Stenotrophomonas maltophilia (6); 
and Gram-positive bacteria, such as Staphylococcus aureus (16).  
 
DISCUSSION  
 
The number of DDD/100 bed-days was 45.83. This number is 
similar to the number of antibiotics used in the surgical wards of 
Dr. Karjadi Hospital in Semarang in 2008, which was 51.8 
DDD/100 patient-days and higher than the DDD/100 bed-days in 
other hospitals in Indonesia.14-17 The number of antibiotics used 
was a combined data from all patients in the surgical wards who 
used antibiotics, unnoticed the diagnosis, thus the value of DDD 
cannot describe its appropriateness to every indication. It is 
necessary to conduct further research that considers the patient 
diagnosis during antibiotic therapy and other factors influencing 
the use of antibiotics. 
 
In the calculation result regarding the number of DDD/100 bed-
days, the major parenteral antibiotics used during the months of 
January to June 2016 were also reported, i.e ceftazidime (6.66 
DDD/100 bed-days). The increase in the use of ceftazidime may 
be due to a shortage of ceftriaxone injection in the Pharmacy 
Department of Bangil Regional General Hospital in early 2016, 
which was most widely used in the surgical wards of Bangil 
Regional General Hospital. A research conducted at Dr. Kariadi 
Hospital in Semarang and other hospitals in Indonesia also 
suggested that the most widely used antibiotics were 
ceftriaxone.14-17 Ceftazidime and ceftriaxone are a third-
generation cephalosporin. Further research regarding the use of 
the third generation cephalosporin in surgical wards is needed. 
 
From the data on DDD/100 bed-days of each antibiotic, the 90% 
DU segment was then calculated to identify the most commonly 
used antibiotics in the hospital. Antibiotics in the 90% DU 
segment in order from largest to smallest were cefadroxil 
(13.8%), ciprofloxacin (12.9%), ceftriaxone (12.2%), 
metronidazole (11.7%), amoxicillin (9.4%), ceftazidime (6.7%), 
cefixime (6.2%), ampicillin/sulbactam (5.4%), levofloxacin 
(5.4%), gentamicin (3.1%), cefuroxime (2.8%). Ceftriaxone, 
ceftazidime, and cefixime are the third-generation cephalosporins 
(25.1%). The third-generation cephalosporins active against 
Gram-positive and Gram-negative bacteria, therefore widely used 
in the hospital.  
 
The use of antibiotics as therapy in patient care greatly affects the 
growth of bacteria, in which they could become resistant to 
antibiotics which shown at the local resistance patterns. In the 
surgical wards of Bangil Regional General Hospital, the culture 
test performed not for every SSI patient and patient who 
diagnosed open fracture. The types of bacteria isolated in the 
surgical wards of Bangil Regional General Hospital, 
Staphylococcus aureus, Acinetobacter sp., Stenotrophomonas 
maltophilia, and Klebsiella pneumoniae are similar to the results 
of a study carried out at a hospital in Yogyakarta during August 
2013-August 2015.18,19 
 
From microbiology data, we can’t obtain microbial patterns 
because the number of isolates of each bacterium was insufficient 
and not all specimens gave positive isolate in the culture test; 
therefore, it was not possible to calculate the sensitivity 
percentages of several antibiotics due to the small number of 
isolates. These sensitivity test bacteria to antibiotics are classified 
into 3 (three) categories, i.e.: usually effective clinically, if the 
antibiotic sensitivity test result is more than 60% of all 
examinations; intermediate effective clinically, if the antibiotic 
sensitivity test result is between 30-60% of all examinations; and 
not effective clinically, if the antibiotic sensitivity test result is 
less than 30% based on the Sanford Guide to Antimicrobial 
Therapy 46th ed, 2016.20 Further research needs a sufficient 
number of isolates and a standard protocol for antibiotic 
susceptibility tests. 
 
Table 1: Patient’s area characteristic 
 
 Surgical ward Obstetrics and gynecology ward Medical ward 
Number of bed 5b 43 104 
Beds Occupancy Rate (BOR) – 73.3% 74.3% 
Number of patienta 3016 2360 4303 
Length of staya 8805 – – 
Bed-days 8805 5802 14218 
a number of patients or patient’s length of stay in six months period, b operating theatre 
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Table 2: The DDD percentage antibiotic use in hospital 
 
Antibiotic class Surgical ward Obstetrics and gynecology ward Medical ward 
Third-generation cephalosporins 29% 2% 38% 
Fluoroquinolones 26% 1% 21% 
Other aminoglycosides 11% 2% 1% 
Imidazole derivatives 9% 4% 11% 
Penicillins with extended spectrum 7% 33% 1% 
First-generation cephalosporins 7% 46% 6% 
Carbapenems 4% 0% 2% 
Nitroimidazole derivatives 4% 1% 4% 
Second-generation cephalosporins 2% 5% 2% 
Combinations of penicillins, incl. beta-lactamase inhibitors 1% 6% 11% 
Macrolides 0% 0% 1% 
Lincosamides 0% 0% 0% 
Tetracyclines 0% 0% 0% 
Amphenicols 0% 0% 0% 
Streptomycins 0% 0% 1% 
Other quinolones 0% 0% 1% 
 
Table 3: Types antibiotics use in the hospital 
 
No Anatomical Therapeutic 
Chemical Classification 
Generic Name Surgical wards Obstetrics and gynecology 
ward 
Medical ward 
   
DDD/100 
Patient-Days 
Drug 
Utilization 
DDD/100 
Patient-
Days 
Drug 
Utilization 
DDD/100 
Patient-Days 
Drug 
Utilization 
 
Tetracyclines 
   
    
1 J01AA02 Doxycycline (O) – – 0.13 0.44% – –  
Amphenicols 
   
    
2 J01BA02 Thiamphenicol – – 0.04 0.13% – – 
3 J01BA01 Chloramphenicol (P) – – – – 0.04 0.07%  
Beta-lactam antibacterials,  penicillins 
  
    
4 J01CA01 Ampicilin (P) 1.09 2.38% 0.03 0.12% 0.05 0.09% 
5 J01CA04 Amoxicillin (O/P) 2.08 4.53% 9.45 32.84% 0.51 0.96% 
6 J01CR01 Ampicillin/Sulbactam 
(P) 
0.40 0.87% 1.30 4.52% 5.23 9.72% 
7 J01CR02 Amoxicilin/Clavulanic 
Acid (O) 
0.12 0.26% 0.32 1.09% 0.54 1.01% 
 
Other beta-lactam antibacterials: cephalosporins 
  
    
8 J01DB04 Cefazolin (P) – – 1.56 5.41% 0.38 0.71% 
9 J01DB05 Cefadroxil (O) 3.00 6.55% 11.64 40.43% 3.07 5.72% 
10 J01DC02 Cefuroxime (P) 0.92 2.00% 1.46 5.08% 1.18 2.19% 
11 J01DD01 Cefotaxime (P) 0.25 0.54% 0.05 0.18% 1.85 3.44% 
12 J01DD02 Ceftazidime (P) 6.66 14.53% 0.08 0.28% 1.89 3.52% 
13 J01DD04 Ceftriaxone (P) 2.19 4.79% 0.51 1.78% 12.99 24.16% 
14 J01DD08 Cefixime (O) 4.27 9.32% 0.02 0.07% 3.68 6.84%  
Other beta-lactam antibacterials: carbapenems 
  
    
15 J01DH02 Meropenem (P) 1.76 3.83% 0.10 0.35% 1.33 2.47%  
Macrolides 
   
    
16 J01FA01 Erythromycin (O) 0.01 0.02% – – 0.00 0.01% 
17 J01FA10 Azithromycin (O) 0.19 0.42% 0.01 0.05% 0.35 0.64%  
Lincosamides 
   
    
18 J01FF01 Clindamycin (O) 0.06 0.13% 0.03 0.09% 0.22 0.41%  
Aminoglycoside antibacterials 
  
    
19 J01GA01 Streptomycin (P) – – – – 0.64 1.18% 
20 J01GB03 Gentamicin (P) 3.32 7.25% 0.48 1.68% 0.24 0.44% 
21 J01GB06 Amikacin (P) 1.83 4.00% – – 0.06 0.12%  
Quinolone antibacterials 
  
    
22 J01MA02 Ciprofloxacin (O/P) 11.78 25.70% 0.15 0.50% 4.60 8.55% 
23 J01MA12 Levofloxacin (P) 0.30 0.66% 0.03 0.12% 6.58 12.24% 
24 J01MB04 Pipemidic acid (O) – – – – 0.37 0.68%  
Imidazole derivatives 
  
    
25 J01XD01 Metronidazole (P) 3.93 8.57% 1.18 4.11% 6.00 11.14% 
26 P01AB01 Metronidazole (O) 1.67 3.64% 0.21 0.74% 2.00 3.71% 
TOTAL 45.83 100.00% 28.78 100.00% 53.76 100.00% 
O, oral; P, parenteral 
 
 
 
 
 
 
 
 
 
 
Rika	Yulia	et	al.	Int.	Res.	J.	Pharm.	2018,	9	(9)	
 
 44	
Table 4: Total Isolates Bacterial in the hospital 
 
Gram of bacteria Type of bacteria Surgery ward Obstetrics and gynecology ward Medical ward 
Gram Negative Acinetobacter Sp. 7 – 1 
Stenotrophomonas maltophilia 4 – 2 
Klebsiella pneumoniae 3 – – 
Escherichia coli 2 4 6 
Enterobacter agglomerans 2 – 1 
Enterobacter aerogenes 1 – – 
Enterobacter cloacae 1 1 1 
Klebsiella ozaenae 1 1 – 
Pragia fontium 1 – – 
Shigella dysenterid 1 – – 
Burkholderia cepacia – 1 – 
Hafnia alvei – 1 – 
Morganella morganii – 1 1 
Serratia odorifera – 1 1 
Enterobacter sp – – 1 
Salmonella sp – – 1 
Total Gram Negative Bacteria 23 10 15 
Gram Positive Staphylococcus aureus 9 5 2 
Staphylococcus haemolyticus – 2 – 
Staphylococcus intermedius – 2 1 
Staphylococcus simulans 1 – – 
Streptococcus mitis 1 – – 
Streptococcus pyogenes 1 1 – 
Staphylococcus xylosus – 1 – 
Staphylococcus schleiferi – 1 – 
Streptococcus suis – 1 – 
Total Gram Positive Bacteria 12 13 3 
TOTAL 35 23 18 
 
 
CONCLUSION  
 
The number of DDD/100 bed-days from three wards of Bangil 
Regional General Hospital was 128.4. The most antibiotics use 
was the third-generation cephalosporins. There were 124 bacteria 
growing during a cultural test carried out on 35 antibiotics, the 
number of Gram-positive bacteria higher than the number of 
Gram-negative bacteria. 
 
Impact on practice: The research will urge the organization to 
obtain sufficient cultural isolates to determine the microbial 
patterns in the Surgery, Obstetrics and Gynecology, and Medical 
Ward of Bangil Regional General Hospital, i.e. to perform a 
bacterial culture on patients who take antibiotics after 3 days, who 
use prophylactic antibiotics and undergo a surgical site infection; 
to evaluate the use of antibiotics regarding patient diagnosis; to 
update the antibiotic therapeutic guideline considering to the 
microbial pattern in the hospital. 
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